Bristol-Myers Squibb Co
The FTC was investigating whether the drugmaker made false statements to it regarding the deal it struck with Canada's Apotex Inc to keep a copycat version of Plavix off the market, the paper said.
Plavix, also known as clopidogrel and made by Sanofi-Aventis SA
Reuters efforts to contact Bristol-Myers out of regular office hours were unsuccessful. In December, Bristol-Myers said it agreed to pay $1.1 million to settle charges connected with an anti-trust investigation by the New York State Attorney General's Office.
(Reporting by S. John Tilak in Bangalore; Editing by Anshuman Daga)